2011 Pipeline Report
HIV, Hepatitis C Virus (HCV), and Tuberculosis Drugs, Diagnostics, Vaccines, and Preventive Technologies in Development Second Edition September 2011 Written by Polly Clayden, Simon Collins, Mark Harrington, Richard Jefferys, Tracy Swan, Javid Syed, and Claire Wingfield with a a contribution…
AIDS Research: Broad Health and Economic Benefits
July 2011 - Investments in health research at the National Institutes of Health (NIH) have paid enormous dividends in the health and well-being of people in the U.S. and around the world. HIV and AIDS research supported by NIH has…
An Exploratory Analysis of HIV Treatment Research and Development Investments in 2009
July 2011 - In 2010, the number of people receiving ART grew by 1.3 million from 5.3 to 6.6 million. Yet, 2.6 million new infections and 1.8 million AIDS deaths occurred. New infections continue to outpace the number of people…
Funding for HIV treatment research exceeded US$ 2.4 billion in 2009
2011 Pipeline Report shows that medical prospects for people with HIV, hepatitis C, and tuberculosis have never been better
Bolder Action Needed by Donor Nations, Less Rhetoric in Fight against HIV/AIDS
Letter to Secretary Clinton on the Global Fund to Fight AIDS, TB, and Malaria
February 7, 2011 Dear Secretary Clinton, We write to ask for your leadership in ensuring The Global Fund to Fight AIDS, TB, and Malaria is “open for new business,” saving lives through expanding programming in 2012. We ask that you…
TAG Recommendations on Clinical Trials Network Restructuring
Treatment Action Group outlines issues of concern and questions about network restructuring research priorities and network structure. Jan 4, 2011 - Treatment Action Group (www.treatmentactiongroup.org) is an independent AIDS research and policy think tank fighting for better treatment, a vaccine,…